Publications by authors named "Jochen Graff"

Claim this Profile
O
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
Emel Aygören-Pürsün, Anette Bygum, Vesna Grivcheva-Panovska, Markus Magerl, Jochen Graff

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber.
Peter Florian, Peter Wonerow, Sebastian Harder, Karina Kuczka, Michel Dubar, Jochen Graff

Eur J Clin Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.
Darja Karpova, Susanne Bräuninger, Eliza Wiercinska, Ariane Krämer, Belinda Stock, Jochen Graff

J Transl Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat.
Emel Aygören-Pürsün, Markus Magerl, Jochen Graff, Inmaculada Martinez-Saguer, Wolfhart Kreuz

J Allergy Clin Immunol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients.
Jochen Graff, Ernst-Heinrich Scheuermann, Gunnar Brandhorst, Michael Oellerich, Jan Gossmann

Ther Drug Monit· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel oral anticoagulants: clinical pharmacology, indications and practical considerations.
Sebastian Harder, Jochen Graff

Eur J Clin Pharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Jochen Graff, Sebastian Harder

Clin Pharmacokinet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet activation markers after conversion from azathioprine to sirolimus based immunosuppression in renal transplant recipients.
Jochen Graff, Sebastian Harder, Claudia Reiche, Ernst-Heinrich Scheuermann, Jan Gossmann

Int J Clin Pharmacol Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
Alexandra Doehring, Nils von Hentig, Jochen Graff, Syavash Salamat, Michael Schmidt

Pharmacogenet Genomics· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
Nils von Hentig, Ann-Kristin Förster, Karina Kuczka, Ute Klinkhardt, Stefan Klauke, Jochen Graff

J Antimicrob Chemother· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.
Jochen Graff, Nils von Hentig, Karina Kuczka, Carlo Angioni, Peter Gute

J Antimicrob Chemother· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
Jochen Graff, Nils von Hentig, Frank Misselwitz, Dagmar Kubitza, Michael Becka

J Clin Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study.
Jochen Graff, Mohammed Arabmotlagh, Raymond Cheung, Gerd Geisslinger, Sebastian Harder

Clin Ther· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the retention test Homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs.
Boris Krischek, Werner Brannath, Ute Klinkhardt, Jochen Graff, Ulrich Wieding

Semin Thromb Hemost· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents.
Jochen Graff, Sebastian Harder

Semin Thromb Hemost· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
Jochen Graff, Sebastian Harder, Oliver Wahl, Ernst-Heinrich Scheuermann, Jan Gossmann

Clin Pharmacol Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.
Daniel Poeckel, Lars Tausch, Anja Altmann, Christian Feisst, Ute Klinkhardt, Jochen Graff

Br J Pharmacol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
Jochen Graff, Ute Klinkhardt, Sebastian Harder

Thromb Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
Sebastian Harder, Jochen Graff, Ute Klinkhardt, Nils von Hentig, Jeanine M Walenga

Thromb Haemost· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans.
Jochen Graff, Ute Klinkhardt, Dagmar Westrup, Carl M Kirchmaier, Hans Klaus Breddin

Br J Clin Pharmacol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Ute Klinkhardt, Rupert Bauersachs, Jan Adams, Jochen Graff, Edeltraud Lindhoff-Last

Clin Pharmacol Ther· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppressive therapy regimen and platelet activation in renal transplant patients.
Jochen Graff, Ute Klinkhardt, Sebastian Harder, Wolfgang Wegert, Tomas Lenz

Clin Pharmacol Ther· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor.
Jochen Graff, Ute Klinkhardt, Valérie B Schini-Kerth, Sebastian Harder, Nicole Franz

J Pharmacol Exp Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model.
Ute Klinkhardt, Jochen Graff, Sebastian Harder

Clin Pharmacol Ther· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis